---
title: 'Solitary pulmonary metastases at first recurrence of osteosarcoma: Presentation,
  treatment, and survival of 219 patients of the Cooperative Osteosarcoma Study Group'
date: '2023-08-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37548393/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230807180848&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Approximately half of the patients who experience a solitary
  pulmonary relapse at first recurrence of osteosarcoma remain alive 5 years after
  this first relapse. Only one third will remain disease-free. A complete surgical
  resection of the lesion is essential for long-term survival while relapse chemotherapy
  does not seem to improve survival. Innovative therapies are required to improve
  ...'
disable_comments: true
---
CONCLUSION: Approximately half of the patients who experience a solitary pulmonary relapse at first recurrence of osteosarcoma remain alive 5 years after this first relapse. Only one third will remain disease-free. A complete surgical resection of the lesion is essential for long-term survival while relapse chemotherapy does not seem to improve survival. Innovative therapies are required to improve ...